VANCOUVER, BRITISH COLUMBIA – TheNewswire - April 20, 2026 - Frequency Exchange Corp. (TSXV: FREQ) (OTC: FRECF) ("Frequency" or the "Company") is pleased to announce that its common shares have been listed on the Frankfurt Stock Exchange ("FSE") under the ticker symbol "YC6". Trading commenced on April 16, 2026.

 

This listing marks an important milestone in the Company’s international expansion and is expected to broaden access to global capital markets, increasing visibility among European institutional and retail investors while also facilitating participation from investors in the Middle East, particularly in the United Arab Emirates, where the Company has established strategic distribution relationships.

 

As one of Europe’s largest and most liquid trading venues, the FSE serves as a key gateway to international capital, supporting improved liquidity, a more diversified shareholder base, and greater accessibility for investors aligned with the Company’s growth objectives.

 

“The commencement of trading on the FSE marks an important step in Frequency’s global expansion and comes at a pivotal time following the relaunch of our NIKKI platform, which combines a one-time hardware purchase with a recurring annual subscription model. Together with our established distribution in the UAE, it strengthens our market reach while building a foundation for scalable and predictable recurring revenue,” said Stephen Davis, CEO of Frequency Exchange.

 

The Company also announces that mwb Wertpapierhandelsbank AG will act as designated market maker, supporting orderly trading and liquidity in Frequency’s shares on the FSE.

 

Trading on the FSE will be conducted in Euros. The Company’s primary listing will remain on TSX Venture Exchange under the symbol “FREQ”, and all regulatory filings and continuous disclosure obligations remain governed by applicable securities laws of that jurisdiction.

 

About Frequency Exchange Corp.

 

Frequency Exchange Corp. is the parent company of FREmedica Technologies Inc., a technology company focused on frequency-based digital wellness solutions designed to support cellular communication and broader wellness applications.

 

Originally developed with applications related to Lyme disease, the NIKKI platform has evolved into a wellness solution addressing sleep, stress, recovery, and performance — areas of increasing demand in international markets, including the Middle East. The Company’s technology is supported by ongoing testing and quality-of-life evaluations.

 

For more information, visit www.FrequencyExchangeCorp.com and www.WeAreNikki.com.

 

Investor Contacts:

 

Stephen Davis

CEO

Frequency Exchange Corp.

stephen@frequencyexchangecorp.com  

 

Nicole Sullivan

President

FREmedica Technologies Inc.

nicole.sullivan@wearenikki.com

 

Forward-Looking Information

 

This news release contains forward-looking statements within the meaning of applicable securities laws. These statements reflect the Company’s current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially. Readers are cautioned not to place undue reliance on forward-looking statements.

 

Additional information identifying risks and uncertainties is contained in filings by the Company with the Canadian securities regulators, which filings are available under the Company’s profile on SEDAR+ at www.sedarplus.ca.

 

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.